Aurobindo Pharma Schedules Investor Meeting with ICICI Securities on 17th Sep'26
Aurobindo Pharma Ltd 路 Intimation 路 11 Sept 2026, 6:42 pm
Aurobindo Pharma Schedules Investor Meeting with ICICI Securities on 17th Sep'26 Aurobindo Pharma announced that company officials will participate in a group investor/analyst meeting organized by ICICI Securities on 17th Sep'26, scheduled from 02:30 PM to 03:30 PM IST in Hyderabad. The company confirmed that no unpublished price sensitive information (UPSI) will be discussed during the interaction.
Original exchange filing (PDF)
More announcements from Aurobindo Pharma Ltd
- Intimation of classification of US FDA inspection at Lannet Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company. 路 12 Nov 2026
- Submission of Earning Call Transcript for Q2FY27. 路 11 Nov 2026
- Unit-2 of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company received Establishment Inspection Report from US FDA with classification as "Voluntary Action Indicated". 路 11 Nov 2026
- Intimation of investors / analysts meet to be held on 17.11.2026. 路 09 Nov 2026
- Intimation of investor / analysts meet to be held on 16.09.2026. 路 09 Nov 2026
- Submission of Financial results for the Quarter and Half year ended September 30, 2026. 路 05 Nov 2026
- Reappointment of Mr. M. R. Kumar as Independent Director of the Company for second term with effect from April 1, 2027. 路 05 Nov 2026
- Transfer of ownership of Auro Pharma LLC, Russia from Auroactive Pharma Private Limited to Auropharm Overseas Limited, Wholly Owned subsidiaries of the Company. 路 05 Nov 2026
